Helping investors discover, understand, and stay up-to-date on opportunities within the Psychedelic industry. Inquiries: hello@psychedelicfinance.com
Joined November 2019
- Tweets 4,295
- Following 153
- Followers 20,891
- Likes 1,335
45 Photos and videos
Pinned Tweet
22 Nov 2019
Welcome to Psychedelic Finance.
We exist to help bridge the gap between the exciting world of psychedelic medicine and the companies being built around it.
If you'd like to see our more detailed research on the industry, you can join the community here:
psychedelicfinance.com/
31
37
137
Psychedelic Finance retweeted
Jun 11
A publicly traded company on the Nasdaq is shipping psilocybin to the United Kingdom. But, why?
$OPTH
thenew.money/article/optimi-…
1
2
6
315
Psychedelic Finance retweeted
Jun 10
Breaking: $OPTH completes its first export of naturally derived psilocybin to the United Kingdom, supplying biomass and finished 5mg capsules for a planned Phase 2 clinical trial under Health Canada and UK Home Office authorization.
1
1
4
251
Psychedelic Finance retweeted
Jun 1
Breaking: $TELIF signs an agreement to deploy its third Self-Driving Lab platform of fiscal 2026 for a major global pharmaceutical company in Europe.
1
5
370
Psychedelic Finance retweeted
May 28
Breaking: $ATAI launches a Patient Impact Grant Program awarding three $20,000 grants to mental health non-profits focused on community support, education, stigma reduction and independent research.
3
10
410
Psychedelic Finance retweeted
May 13
Breaking: $CMPS reports Q1 2026 results with cash and cash equivalents of ~$216M, providing runway into 2027 as it advances late-stage COMP360 psilocybin trials toward potential commercialization for treatment-resistant depression.
2
2
11
813
Psychedelic Finance retweeted
Apr 20
Psychedelic medicines are getting a big boost of support from the White House.
And it might be just the beginning of reshaping the future of psychedelic drugs in America.
thenew.money/article/theres-…
2
6
15
698
Psychedelic Finance retweeted
Mar 17
Breaking: $ATAI says BPL-003 shows rapid and durable antidepressant effects in treatment-resistant depression, supporting Phase 3 trials set to begin in Q2 2026.
5
2
9
596
Deepfakes are a massive problem that could undermine the integrity of our health care systems and beyond.
Glad to see more focus on addressing the need for authentication in the future of media, communication, and security.
1
1
3
500
Psychedelic Finance retweeted
Feb 17
Breaking: $CMPS reports its COMP360 psilocybin treatment met the primary endpoint in its second Phase 3 trial for treatment-resistant depression.
3
1
13
1,106
Psychedelic Finance retweeted
Jan 24
Our next newsletter goes out soon.
Discover the week's biggest news, top performing companies, and the Trends that moved markets.
Join free: thenew.money/join
3
4
584
Psychedelic Finance retweeted
Jan 21
Billionaire @C_Angermayer is one of the world’s most prolific entrepreneurs and investors in technology and biotech.
And his psychedelic drug development company is on a mission to change the future of psychedelic medicines in America.
$ATAI
thenew.money/article/christi…
2
14
1,118
Psychedelic Finance retweeted
Jan 17
This Week's Top Performing Trends
13.6% | Data Centre Stocks
11.8% | Mike Alfred
11.7% | Critical Minerals
11.7% | Future of Food
11.7% | Solar Power Stocks
1
3
6
696
Psychedelic Finance retweeted
Jan 7
Breaking: $CMPS gets FDA acceptance of its IND application for COMP360 in PTSD, enabling initiation of a late-stage clinical trial and hosting a webinar on PTSD and treatment-resistant depression.
1
4
567
Psychedelic Finance retweeted
Jan 5
2
6
998
Psychedelic Finance retweeted
Jan 1
Top Performing Trends and Investors of 2025:
Robert Friedland 1,076%
Silver Stocks 320%
Eric Sprott 288%
America Backed 157%
Rare Earth Elements 141%
Gold Stocks 123%
Critical Minerals 113%
Mike Alfred 109%
Eric Jackson 105%
Stanley Druckenmiller 96%
Drone Stocks 92%
1
6
26
68,549
Psychedelic Finance retweeted
11 Dec 2025
Discover the market's most notable options buys in real time on @TheNewMoney_app.
11 Dec 2025
$1,258,879 of $OKLO $145 calls were just purchased at $13.85 per contract.
Expiring May 15, 2026.
1
2
848